Cinqair Approved for Severe Asthma

WEDNESDAY, March 23, 2016 — Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older.
The drug is to be used in combination with other medications, the agency noted.
In a…
Source: Topamax